<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39550578</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-422X</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>16</Day></PubDate></JournalIssue><Title>Virology journal</Title><ISOAbbreviation>Virol J</ISOAbbreviation></Journal><ArticleTitle>Altered colonic microflora and its metabolic profile in mice with acute viral myocarditis induced by coxsackievirus B3.</ArticleTitle><Pagination><StartPage>295</StartPage><MedlinePgn>295</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">295</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12985-024-02571-z</ELocationID><Abstract><AbstractText>Mounting evidence suggests that the gut-heart axis is critical in the pathogenesis of cardiovascular diseases. The gut serves as the primary pathway through which Coxsackievirus B3 (CVB3) infects its host, leading to acute viral myocarditis (AVMC). However, little is known about the role of gut microflora and its metabolites in the development of AVMC. The AVMC model was established by intraperitoneal injection of CVB3 in mice. Then, 16S ribosomal RNA (16S rRNA) gene sequencing and ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) untargeted metabolomics profiling were performed to analyze the microflora composition and metabolic profile of colonic contents. Compared to the Control mice, the AVMC mice displayed a significant reduction in gut microflora richness and diversity, as revealed by an increased abundance of Proteobacteria and a decreased abundance of Cyanobacteria and Desulfobacterota. LEfSe analysis indicated that the main genera differing between the two groups were Escherichia-Shigella, Lactobacillus, Clostridium_sensu_stricto_1, Prevotellaceae_UCG-001, and Odoribacter. Based on the criterion of OPLS-DA VIP ≥ 1.0 and p-value &lt; 0.05, a total of 198 differential metabolites (DMs) were identified in the gut, including 79 upregulated and 119 downregulated metabolites, of which lipids and lipid-like molecules accounted for the largest proportion. Notably, both altered gut bacterial taxa and metabolites were significantly enriched in the Lipid metabolism pathway, with Traumatic acid (TA), Alpha-Linolenic acid (ALA), Eicosapentaenoic acid (EPA), and Docosahexaenoic acid (DHA) being the key DMs in the pathway. Additionally, significant positive correlations (|r| &gt; 0.80 and p &lt; 0.05) were found between TA levels and Anaerotruncus and Bilophila abundance, between EPA levels and Clostridium_sensu_stricto_1 abundance, and between DHA levels and Escherichia-Shigella abundance, respectively. CVB3 infection leads to notable alterations in gut microflora composition and its metabolic profile, which may participate in AVMC development. Our findings provide important clues for future in-depth studies on AVMC etiology.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Xue</LastName><ForeName>Yimin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Fourth Department of Critical Care Medicine, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fujian Provincial Key Laboratory of Emergency Medicine, Fuzhou, 350001, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lin</LastName><ForeName>Shirong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Emergency, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fujian Provincial Key Laboratory of Emergency Medicine, Fuzhou, 350001, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chen</LastName><ForeName>Mingguang</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fourth Department of Critical Care Medicine, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fujian Provincial Key Laboratory of Emergency Medicine, Fuzhou, 350001, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ke</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Emergency, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fujian Provincial Key Laboratory of Emergency Medicine, Fuzhou, 350001, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jiuyun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Emergency, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fujian Provincial Key Laboratory of Emergency Medicine, Fuzhou, 350001, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Qiaolian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Fourth Department of Critical Care Medicine, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fujian Provincial Key Laboratory of Emergency Medicine, Fuzhou, 350001, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yimei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Emergency, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fujian Provincial Key Laboratory of Emergency Medicine, Fuzhou, 350001, Fujian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Feng</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Emergency, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fujian Provincial Key Laboratory of Emergency Medicine, Fuzhou, 350001, Fujian, China. fjslchenfeng@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2023Y9287</GrantID><Agency>Joint Funds for the Innovation of Science and Technology, Fujian Province</Agency><Country /></Grant><Grant><GrantID>2023GGA009</GrantID><Agency>Fujian Provincial Health Technology Project</Agency><Country /></Grant><Grant><GrantID>2022ZD01008</GrantID><Agency>Fujian Provincial Health Technology Project</Agency><Country /></Grant><Grant><GrantID>2022J01402</GrantID><Agency>Fujian Provincial Natural Science Foundation</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Virol J</MedlineTA><NlmUniqueID>101231645</NlmUniqueID><ISSNLinking>1743-422X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012336">RNA, Ribosomal, 16S</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="Y">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055442" MajorTopicYN="Y">Metabolome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012336" MajorTopicYN="N">RNA, Ribosomal, 16S</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003106" MajorTopicYN="N">Colon</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001419" MajorTopicYN="N">Bacteria</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055432" MajorTopicYN="N">Metabolomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053719" MajorTopicYN="N">Tandem Mass Spectrometry</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute viral myocarditis</Keyword><Keyword MajorTopicYN="N">Coxsackievirus B3</Keyword><Keyword MajorTopicYN="N">Gut microflora</Keyword><Keyword MajorTopicYN="N">Gut-heart axis</Keyword><Keyword MajorTopicYN="N">Metabolomics</Keyword></KeywordList><CoiStatement><b>Declarations</b> <b>Ethics statement</b> All animal protocols were evaluated and approved by the Institutional Animal Care and Use Committee of Fujian Provincial Hospital (Permit No. IACUC-FPH-SL-20231020[0219]). <b>Competing interests</b> The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>17</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>17</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>16</Day><Hour>23</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39550578</ArticleId><ArticleId IdType="doi">10.1186/s12985-024-02571-z</ArticleId><ArticleId IdType="pii">10.1186/s12985-024-02571-z</ArticleId><ArticleId IdType="pmc">PMC11568606</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gupta S, Markham DW, Drazner MH, Mammen PP. Fulminant myocarditis. Nat Clin Pract Cardiovasc Med. 2008;5(11):693–706. 10.1038/ncpcardio1331</Citation><ArticleIdList><ArticleId IdType="pubmed">18797433</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma AN, Stultz JR, Bellamkonda N, Amsterdam EA. Fulminant myocarditis: epidemiology, pathogenesis, diagnosis, and management. Am J Cardiol. 2019;124(12):1954–60. 10.1016/j.amjcard.2019.09.017</Citation><ArticleIdList><ArticleId IdType="pubmed">31679645</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou N, Zhao Y, Jiang J, Shen L, Li J, Wan J, Ma X, Zhang J, Ammirati E, Wang DW. Impact of mechanical circulatory support and immunomodulation therapy on outcome of patients with fulminant myocarditis: Chinese registry of fulminant myocarditis. Signal Transduct Target Ther. 2021;6(1):350. 10.1038/s41392-021-00700-6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8492670</ArticleId><ArticleId IdType="pubmed">34611131</ArticleId></ArticleIdList></Reference><Reference><Citation>Farinha IT, Miranda JO. Myocarditis in paediatric patients: unveiling the progression to dilated cardiomyopathy and heart failure. J Cardiovasc Dev Dis. 2016;3(4):31. 10.3390/jcdd3040031</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5715726</ArticleId><ArticleId IdType="pubmed">29367574</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian Q, Xiong S, Xu W. Manipulating intestinal immunity and microflora: an alternative solution to viral myocarditis? Future Microbiol. 2012;7(10):1207–16. 10.2217/fmb.12.96</Citation><ArticleIdList><ArticleId IdType="pubmed">23030425</ArticleId></ArticleIdList></Reference><Reference><Citation>Caricilli AM, Castoldi A, Câmara NO. Intestinal barrier: a gentlemen’s agreement between microbiota and immunity. World J Gastrointest Pathophysiol. 2014;5(1):18–32. 10.4291/wjgp.v5.i1.18</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4024517</ArticleId><ArticleId IdType="pubmed">24891972</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdes AM, Walter J, Segal E, Spector TD. Role of the gut microbiota in nutrition and health. BMJ. 2018;361:k2179. 10.1136/bmj.k2179</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6000740</ArticleId><ArticleId IdType="pubmed">29899036</ArticleId></ArticleIdList></Reference><Reference><Citation>Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157(1):121–41. 10.1016/j.cell.2014.03.011</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4056765</ArticleId><ArticleId IdType="pubmed">24679531</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Zhao Y. Gut microbiota derived metabolites in cardiovascular health and disease. Protein Cell. 2018;9(5):416–31. 10.1007/s13238-018-0549-0</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5960473</ArticleId><ArticleId IdType="pubmed">29725935</ArticleId></ArticleIdList></Reference><Reference><Citation>Din AU, Hassan A, Zhu Y, Yin T, Gregersen H, Wang G. Amelioration of TMAO through probiotics and its potential role in atherosclerosis. Appl Microbiol Biotechnol. 2019;103(23–24):9217–28. 10.1007/s00253-019-10142-4</Citation><ArticleIdList><ArticleId IdType="pubmed">31655880</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki T, Heaney LM, Jones DJ, Ng LL. Trimethylamine N-oxide and risk stratification after acute myocardial infarction. Clin Chem. 2017;63(1):420–8. 10.1373/clinchem.2016.264853</Citation><ArticleIdList><ArticleId IdType="pubmed">28062632</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen K, Zheng X, Feng M, Li D, Zhang H. Gut microbiota-dependent metabolite trimethylamine N-Oxide contributes to cardiac dysfunction in western diet-induced obese mice. Front Physiol. 2017;8:139. 10.3389/fphys.2017.00139</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5359299</ArticleId><ArticleId IdType="pubmed">28377725</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang WH, Wang Z, Fan Y, Levison B, Hazen JE, Donahue LM, Wu Y, Hazen SL. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis. J Am Coll Cardiol. 2014;64(18):1908–14. 10.1016/j.jacc.2014.02.617</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4254529</ArticleId><ArticleId IdType="pubmed">25444145</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu T, Wu Q, Yao Q, Jiang K, Yu J, Tang Q. Short-chain fatty acid metabolism and multiple effects on cardiovascular diseases. Ageing Res Rev. 2022;81:101706. 10.1016/j.arr.2022.101706</Citation><ArticleIdList><ArticleId IdType="pubmed">35932976</ArticleId></ArticleIdList></Reference><Reference><Citation>Lymperopoulos A, Suster MS, Borges JI. Short-chain fatty acid receptors and cardiovascular function. Int J Mol Sci. 2022;23(6):3303. 10.3390/ijms23063303</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8952772</ArticleId><ArticleId IdType="pubmed">35328722</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Y, Cai X, Fei W, Ye Y, Zhao M, Zheng C. The role of short-chain fatty acids in immunity, inflammation and metabolism. Crit Rev Food Sci Nutr. 2022;62(1):1–12. 10.1080/10408398.2020.1854675</Citation><ArticleIdList><ArticleId IdType="pubmed">33261516</ArticleId></ArticleIdList></Reference><Reference><Citation>Pushpass RG, Alzoufairi S, Jackson KG, Lovegrove JA. Circulating bile acids as a link between the gut microbiota and cardiovascular health: impact of prebiotics, probiotics and polyphenol-rich foods. Nutr Res Rev. 2022;35(2):161–80. 10.1017/S0954422421000081</Citation><ArticleIdList><ArticleId IdType="pubmed">33926590</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai MS, Shabier Z, Taylor M, Lam F, Thevananther S, Kosters A, Karpen SJ. Hypertrophic cardiomyopathy and dysregulation of cardiac energetics in a mouse model of biliary fibrosis. Hepatology. 2010;51(6):2097–107. 10.1002/hep.23585</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3678910</ArticleId><ArticleId IdType="pubmed">20512997</ArticleId></ArticleIdList></Reference><Reference><Citation>Bui TVA, Hwangbo H, Lai Y, Hong SB, Choi YJ, Park HJ, Ban K. The gut-heart axis: updated review for the roles of microbiome in cardiovascular health. Korean Circ J. 2023;53(8):499–518. 10.4070/kcj.2023.0048</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10435824</ArticleId><ArticleId IdType="pubmed">37525495</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu XF, Zhang WY, Wen Q, Chen WJ, Wang ZM, Chen J, Zhu F, Liu K, Cheng LX, Yang J, Shu YW. Fecal microbiota transplantation alleviates myocardial damage in myocarditis by restoring the microbiota composition. Pharmacol Res. 2019;139:412–21. 10.1016/j.phrs.2018.11.042</Citation><ArticleIdList><ArticleId IdType="pubmed">30508676</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong Q, Chen L, Zeng X, Lu F, Huang Y, Wu W. Alterations of the gut microbiome and metabolic profile in CVB3-induced mice acute viral myocarditis. BMC Microbiol. 2023;23(1):139. 10.1186/s12866-023-02863-4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10193676</ArticleId><ArticleId IdType="pubmed">37202726</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue Y, Ke J, Zhang J, Chen M, Zeng L, Fan Q, Zheng C, Chen F. Analysis of long noncoding RNAs and messenger RNAs expression profiles in the hearts of mice with acute viral myocarditis. J Med Virol. 2023;95(2):e28473. 10.1002/jmv.28473</Citation><ArticleIdList><ArticleId IdType="pubmed">36606604</ArticleId></ArticleIdList></Reference><Reference><Citation>Grabie N, Delfs MW, Westrich JR, Love VA, Stavrakis G, Ahmad F, Seidman CE, Seidman JG, Lichtman AH. IL-12 is required for differentiation of pathogenic CD8 + T cell effectors that cause myocarditis. J Clin Invest. 2003;111(5):671–80. 10.1172/JCI16867</Citation><ArticleIdList><ArticleId IdType="pmc">PMC151896</ArticleId><ArticleId IdType="pubmed">12618521</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Zhou Y, Chen Y, Gu J. Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34(17):i884–90. 10.1093/bioinformatics/bty560</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6129281</ArticleId><ArticleId IdType="pubmed">30423086</ArticleId></ArticleIdList></Reference><Reference><Citation>Magoč T, Salzberg SL. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics. 2011;27(21):2957–63. 10.1093/bioinformatics/btr507</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3198573</ArticleId><ArticleId IdType="pubmed">21903629</ArticleId></ArticleIdList></Reference><Reference><Citation>Edgar RC, Flyvbjerg H. Error filtering, pair assembly and error correction for next-generation sequencing reads. Bioinformatics. 2015;31(21):3476–82. 10.1093/bioinformatics/btv401</Citation><ArticleIdList><ArticleId IdType="pubmed">26139637</ArticleId></ArticleIdList></Reference><Reference><Citation>Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, Peplies J, Glöckner FO. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2013;41(Database issue):D590–6. 10.1093/nar/gks1219</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3531112</ArticleId><ArticleId IdType="pubmed">23193283</ArticleId></ArticleIdList></Reference><Reference><Citation>Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7(5):335–6. 10.1038/nmeth.f.303</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3156573</ArticleId><ArticleId IdType="pubmed">20383131</ArticleId></ArticleIdList></Reference><Reference><Citation>Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60. 10.1186/gb-2011-12-6-r60</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3218848</ArticleId><ArticleId IdType="pubmed">21702898</ArticleId></ArticleIdList></Reference><Reference><Citation>Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, Clemente JC, Burkepile DE, Vega Thurber RL, Knight R, Beiko RG, Huttenhower C. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol. 2013;31(9):814–21. 10.1038/nbt.2676</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3819121</ArticleId><ArticleId IdType="pubmed">23975157</ArticleId></ArticleIdList></Reference><Reference><Citation>Want EJ, Masson P, Michopoulos F, Wilson ID, Theodoridis G, Plumb RS, Shockcor J, Loftus N, Holmes E, Nicholson JK. Global metabolic profiling of animal and human tissues via UPLC-MS. Nat Protoc. 2013;8(1):17–32. 10.1038/nprot.2012.135</Citation><ArticleIdList><ArticleId IdType="pubmed">23222455</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai W, Xie D, Lu M, Li P, Lv H, Yang C, Peng Q, Zhu Y, Guo L, Zhang Y, Tan J, Lin Z. Characterization of white tea metabolome: comparison against green and black tea by a nontargeted metabolomics approach. Food Res Int. 2017;96:40–5. 10.1016/j.foodres.2017.03.028</Citation><ArticleIdList><ArticleId IdType="pubmed">28528106</ArticleId></ArticleIdList></Reference><Reference><Citation>Worley B, Powers R. Multivariate analysis in metabolomics. Curr Metabolomics. 2013;1(1):92–107. 10.2174/2213235X11301010092</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4465187</ArticleId><ArticleId IdType="pubmed">26078916</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia J, Wishart DS. MetPA: a web-based metabolomics tool for pathway analysis and visualization. Bioinformatics. 2010;26(18):2342–4. 10.1093/bioinformatics/btq418</Citation><ArticleIdList><ArticleId IdType="pubmed">20628077</ArticleId></ArticleIdList></Reference><Reference><Citation>Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell. 2006;124(4):837–48. 10.1016/j.cell.2006.02.017</Citation><ArticleIdList><ArticleId IdType="pubmed">16497592</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Q, Deng J, Pan X, Meng D, Zhu Y, Bai Y, Shi C, Duan Y, Wang T, Li X, Sluijter JP, Xiao J. Gut microbiome mediates the protective effects of exercise after myocardial infarction. Microbiome. 2022;10(1):82. 10.1186/s40168-022-01271-6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9153113</ArticleId><ArticleId IdType="pubmed">35637497</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G, Wu S, Liu W, Cui Q, Geng B, Zhang W, Weldon R, Auguste K, Yang L, Liu X, Chen L, Yang X, Zhu B, Cai J. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 2017;5(1):14. 10.1186/s40168-016-0222-x</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5286796</ArticleId><ArticleId IdType="pubmed">28143587</ArticleId></ArticleIdList></Reference><Reference><Citation>Luedde M, Winkler T, Heinsen FA, Rühlemann MC, Spehlmann ME, Bajrovic A, Lieb W, Franke A, Ott SJ, Frey N. Heart failure is associated with depletion of core intestinal microbiota. ESC Heart Fail. 2017;4(3):282–90. 10.1002/ehf2.12155</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5542738</ArticleId><ArticleId IdType="pubmed">28772054</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin NR, Whon TW, Bae JW. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 2015;33(9):496–503. 10.1016/j.tibtech.2015.06.011</Citation><ArticleIdList><ArticleId IdType="pubmed">26210164</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Ran L, Yang Y, Gao X, Peng M, Liu S, Sun L, Wan J, Wang Y, Yang K, Yin M, Chunyu W. Deferasirox alleviates DSS-induced ulcerative colitis in mice by inhibiting ferroptosis and improving intestinal microbiota. Life Sci. 2023;314:121312. 10.1016/j.lfs.2022.121312</Citation><ArticleIdList><ArticleId IdType="pubmed">36563842</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Yu Z, Tian F, Zhao J, Zhang H, Zhai Q, Chen W. Surface components and metabolites of probiotics for regulation of intestinal epithelial barrier. Microb Cell Fact. 2020;19(1):23. 10.1186/s12934-020-1289-4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7003451</ArticleId><ArticleId IdType="pubmed">32024520</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan KL. Infection, illness, and fenugreek seeds: was illness a good enough proxy for infection in the 2011 outbreak of shiga toxin-producing Escherichia coli O104:H4 in France? Clin Infect Dis. 2013;56(7):1055–6. 10.1093/cid/cis1023</Citation><ArticleIdList><ArticleId IdType="pubmed">23223592</ArticleId></ArticleIdList></Reference><Reference><Citation>De la Fuente M, Franchi L, Araya D, Díaz-Jiménez D, Olivares M, Álvarez-Lobos M, Golenbock D, González MJ, López-Kostner F, Quera R, Núñez G, Vidal R, Hermoso MA. Escherichia coli isolates from inflammatory bowel diseases patients survive in macrophages and activate NLRP3 inflammasome. Int J Med Microbiol. 2014;304(3–4):384–92. 10.1016/j.ijmm.2014.01.002</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4075040</ArticleId><ArticleId IdType="pubmed">24581881</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattaneo A, Cattane N, Galluzzi S, Provasi S, Lopizzo N, Festari C, Ferrari C, Guerra UP, Paghera B, Muscio C, Bianchetti A, Volta GD, Turla M, Cotelli MS, Gennuso M, Prelle A, Zanetti O, Lussignoli G, Mirabile D, Bellandi D, Gentile S, Belotti G, Villani D, Harach T, Bolmont T, Padovani A, Boccardi M, Frisoni GB. INDIA-FBP Group. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging. 2017;49:60–8. 10.1016/j.neurobiolaging.2016.08.019</Citation><ArticleIdList><ArticleId IdType="pubmed">27776263</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Li T, Wu H, Shi H, Bai J, Zhao W, Jiang D, Jiang X. Lactobacillus rhamnosus GG strain mitigated the development of obstructive sleep apnea-induced hypertension in a high salt diet via regulating TMAO level and CD4 + T cell induced-type I inflammation. Biomed Pharmacother. 2019;112:108580. 10.1016/j.biopha.2019.01.041</Citation><ArticleIdList><ArticleId IdType="pubmed">30784906</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervantes-Barragan L, Chai JN, Tianero MD, Di Luccia B, Ahern PP, Merriman J, Cortez VS, Caparon MG, Donia MS, Gilfillan S, Cella M, Gordon JI, Hsieh CS, Colonna M. Lactobacillus reuteri induces gut intraepithelial CD4 + CD8αα + T cells. Science. 2017;357(6353):806–10. 10.1126/science.aah5825</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5687812</ArticleId><ArticleId IdType="pubmed">28775213</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng Y, Yue Y, Guan Q, Ren Y, Guo L, Fan Y, Lu ZM, Shi JS, Xu ZH. Cereal vinegar sediment alleviates spontaneous Ulcerative Colitis in Il-10 deficient mice. Mol Nutr Food Res. 2021;65(24):e2001227. 10.1002/mnfr.202001227</Citation><ArticleIdList><ArticleId IdType="pubmed">34699119</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Yang H, Zhao Q, Wang X, Zhang J, Zhao X. Polyphenol-Rich Loquat Fruit Extract prevents Fructose-Induced nonalcoholic fatty liver disease by modulating glycometabolism, lipometabolism, oxidative stress, inflammation, intestinal barrier, and gut microbiota in mice. J Agric Food Chem. 2019;67(27):7726–37. 10.1021/acs.jafc.9b02523</Citation><ArticleIdList><ArticleId IdType="pubmed">31203627</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue Y, Zhang Q, Wang J. Integrated gas chromatograph-mass spectrometry (GC/MS) and MS/MS-based molecular networking reveals the analgesic and anti-inflammatory phenotypes of the sea slater Ligia exotica. Mar Drugs. 2019;17(7):395. 10.3390/md17070395</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6669569</ArticleId><ArticleId IdType="pubmed">31277424</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramanathan S, Ravindran D, Arunachalam K, Arumugam VR. Inhibition of quorum sensing-dependent biofilm and virulence genes expression in environmental pathogen Serratia marcescens by petroselinic acid. Antonie Van Leeuwenhoek. 2018;111(4):501–15. 10.1007/s10482-017-0971-y</Citation><ArticleIdList><ArticleId IdType="pubmed">29101490</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang W, Yan Y, Wu M, Hu J, Zhao J, Chen X, Liu W, Liu K, Li C. Preoperative fasting confers protection against intestinal ischaemia/reperfusion injury by modulating gut microbiota and their metabolites in a mouse model. Br J Anaesth. 2022;128(3):501–12. 10.1016/j.bja.2021.11.025</Citation><ArticleIdList><ArticleId IdType="pubmed">34930601</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang RP, Cai DK, Chen YX, Gang HN, Wei M, Zhu DQ, Li SM, Yang JM, Luo SN, Bi XL, Sun DM. Metabolic insight into the neuroprotective effect of Tao-He-Cheng-Qi (THCQ) decoction on ICH rats using untargeted metabolomics. Front Pharmacol. 2021;12:636457. 10.3389/fphar.2021.636457</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8126979</ArticleId><ArticleId IdType="pubmed">34012394</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha SR, Haileselassie Y, Nguyen LP, Tropini C, Wang M, Becker LS, Sim D, Jarr K, Spear ET, Singh G, Namkoong H, Bittinger K, Fischbach MA, Sonnenburg JL, Habtezion A. Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation. Cell Host Microbe. 2020;27(4):659–e6705. 10.1016/j.chom.2020.01.021</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8172352</ArticleId><ArticleId IdType="pubmed">32101703</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng P, Li Q, Liu L, Wang S, Wu Z, Tao Y, Huang P, Wang P. Crocetin prolongs recovery period of DSS-induced colitis via altering intestinal microbiome and increasing intestinal permeability. Int J Mol Sci. 2022;23(7):3832. 10.3390/ijms23073832</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8998954</ArticleId><ArticleId IdType="pubmed">35409192</ArticleId></ArticleIdList></Reference><Reference><Citation>Yates CM, Calder PC, Ed Rainger G. Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease. Pharmacol Ther. 2014;141(3):272–82. 10.1016/j.pharmthera.2013.10.010</Citation><ArticleIdList><ArticleId IdType="pubmed">24201219</ArticleId></ArticleIdList></Reference><Reference><Citation>Radzikowska U, Rinaldi AO, Çelebi Sözener Z, Karaguzel D, Wojcik M, Cypryk K, Akdis M, Akdis CA, Sokolowska M. The influence of dietary fatty acids on immune responses. Nutrients. 2019;11(12):2990. 10.3390/nu11122990</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6950146</ArticleId><ArticleId IdType="pubmed">31817726</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson H, Mitra S, Croden FC, Taylor M, Wood HM, Perry SL, Spencer JA, Quirke P, Toogood GJ, Lawton CL, Dye L, Loadman PM, Hull MA. A randomised trial of the effect of omega-3 polyunsaturated fatty acid supplements on the human intestinal microbiota. Gut. 2018;67(11):1974–83. 10.1136/gutjnl-2017-314968</Citation><ArticleIdList><ArticleId IdType="pubmed">28951525</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim RRX, Park MA, Wong LH, Haldar S, Lim KJ, Nagarajan N, Henry CJ, Jiang YR, Moskvin OV. Gut microbiome responses to dietary intervention with hypocholesterolemic vegetable oils. NPJ Biofilms Microbiomes. 2022;8(1):24. 10.1038/s41522-022-00287-y</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9001705</ArticleId><ArticleId IdType="pubmed">35411007</ArticleId></ArticleIdList></Reference><Reference><Citation>Siracusa R, Impellizzeri D, Cordaro M, Gugliandolo E, Peritore AF, Di Paola R, Cuzzocrea S. Topical application of adelmidrol + trans-traumatic acid enhances skin wound healing in a streptozotocin-induced diabetic mouse model. Front Pharmacol. 2018;9:871. 10.3389/fphar.2018.00871</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6115498</ArticleId><ArticleId IdType="pubmed">30190675</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Q, Yu J, Zhou H, Wang X, Zhang C, Hu J, Hu Y, Zheng H, Zeng F, Yue C, Gu L, Wang Z, Zhao F, Zhou P, Zhang H, Huang N, Wu W, Zhou Y, Li J. Intestinal dysbiosis exacerbates the pathogenesis of psoriasis-like phenotype through changes in fatty acid metabolism. Signal Transduct Target Ther. 2023;8(1):40. 10.1038/s41392-022-01219-0</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9884668</ArticleId><ArticleId IdType="pubmed">36710269</ArticleId></ArticleIdList></Reference><Reference><Citation>An L, Wuri J, Zheng Z, Li W, Yan T. Microbiota modulate doxorubicin induced cardiotoxicity. Eur J Pharm Sci. 2021;166:105977. 10.1016/j.ejps.2021.105977</Citation><ArticleIdList><ArticleId IdType="pubmed">34416387</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y, Zhang Y, Han X, Yuan Y, Zhou Y, Gao Y, Yu H, Zhang J, Shi Y, Duan Y, Zhao X, Yan S, Hao H, Dai C, Zhao S, Shi J, Li W, Zhang S, Xu W, Fang N, Gong Y, Li Y. Akkermansia muciniphila prevents cold-related atrial fibrillation in rats by modulation of TMAO induced cardiac pyroptosis. EBioMedicine. 2022;82:104087. 10.1016/j.ebiom.2022.104087</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9270211</ArticleId><ArticleId IdType="pubmed">35797768</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim ES, Yoon BH, Lee SM, Choi M, Kim EH, Lee BW, Kim SY, Pack CG, Sung YH, Baek IJ, Jung CH, Kim TB, Jeong JY, Ha CH. Fecal microbiota transplantation ameliorates atherosclerosis in mice with C1q/TNF-related protein 9 genetic deficiency. Exp Mol Med. 2022;54(2):103–14. 10.1038/s12276-022-00728-w</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8894390</ArticleId><ArticleId IdType="pubmed">35115674</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>